Transdermal buprenorphine combined with spinal morphine and naropine for pain relief in chronic peripheral vasculopathy

Minerva Anestesiologica

Volumn 71, Issue 7-8, 2005, Pages 445-449

  Aurilio, Caterina ^a,b   Pace, M C ^a   Passavanti, M B ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE   (Italy)

Author keywords

Buprenorphine; Ischemia; Pain; Peripheral vascular diseases

Indexed keywords

BUPRENORPHINE; MORPHINE; MORPHINE DERIVATIVE; MU OPIATE RECEPTOR; NAROPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OPIATE AGONIST; UNCLASSIFIED DRUG;

ANALGESIA; ANALGESIC ACTIVITY; ANTINOCICEPTION; ARTICLE; CHRONIC DISEASE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DROWSINESS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; EPIDURAL ANESTHESIA; FATIGUE; HUMAN; INCIDENCE; LOW DRUG DOSE; NAUSEA; NAUSEA AND VOMITING; PERIPHERAL VASCULAR DISEASE; RESPIRATORY FAILURE; SPINAL CORD; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADMINISTRATION, CUTANEOUS; ANALGESICS, OPIOID; BUPRENORPHINE; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; HUMANS; INJECTIONS, SPINAL; MORPHINE; PAIN; PAIN MEASUREMENT; PERIPHERAL VASCULAR DISEASES;

EID: 33745312699     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Sorge J, Werry C, Pichlmayr I. Strong opioids for treatment of chronic pain: a meta-analysis. Schmerz 1997;11: 400-10. German.
2. Stock C, Shum JH. Buprenorphine: a new pharmacotherapy for opioid addictions treatment. J Pain Palliat Care Pharmacother 2004;18:35-54.
3. Likar R, Griessinger N, Sadjak A, Sittl R. Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain. Wien Med Wochenschr 2003;153:317-22 German.
4. Sittl P, Griessinger, N, Likar, R. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial. Clin Ther 2003;25: 150-68.
5. Budd K. Buprenorphine and the transdermal system: the ideal match in pain management. Int J Clin Pract Suppl 2003;133:9-14; discussion 234.
6. Radbruch L. Buprenorphine TDS: use in daily practice, benefits for patients. Int J Clin Pract Suppl 2003; 133:19-22; discussion 23-4.
7. Thompson AC, Kristal MB, Sallaj A, Acheson A, Martin LB, Martin T. Analgesic efficacy of orally administered buprenorphine in rats: methodologic considerations. Comp Med 2004;54:293-300.
8. Radbruch L, Vielvoye-Kerkmeer A. Buprenorphine TDS: the clinical development rationale and results. Int J Clin Pract Suppl 2003;133:15-8; discussion 23-4.
9. Evans HC, Easthope SE. Transdermal buprenorphine. Drugs 2003;63:1999-2010; discussion 2011-2.
10. Lutfy K, Eitan S, Bryant CD, Yang YC, Saliminejad N, Walwyn W et al. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J Neurosci 2003;23:10331-7.
11. Mizoguchi H, Spaulding A, Leitermann R, Wu HE, Nagase H, Tseng LF. Buprenorphine blocks epsilonand micro-opioid receptor-mediated antinociception in the mouse. J Pharmacol Exp Ther 2003;306: 394-400.
12. Beltrutti D, Niv D, Ben-Abraham R, Di Santo S, Weinbroum AA. Late antinociception and lower untoward effects of concomitant intrathecal morphine and intravenous buprenorphine in humans. J Clin Anesth 2002;14:441-6.
13. Ben-Abraham F, Beltrutti D, Niv D, Weinbroum A. The benefit of combining spinal morphine and intravenous buprenorphine for perioperative pain. Harefuah 2001; 140:709-12, 806. Hebrew.
14. Chen LH, Nemirovsky A, Gong QY. Interaction of combined administration of intrathecal morphine with subcutaneous morphine or buprenorphine. Acta Pharmacol Sin 2000;21:685-9.
15. Nemirovsky A, Chen L, Zelman V, Jurna I. The antinociceptive effect of the combination of spinal morphine with systemic morphine or buprenorphine. Anesth Analg 2001;93:197-203,